In the BioHarmony Drug Report Database

"Preview" Icon

Lonafarnib

Zokinvy (lonafarnib) is a small molecule pharmaceutical. Lonafarnib was first approved as Zokinvy on 2020-11-20. It is known to target GTPase NRas, GTPase HRas, GTPase KRas, and protein farnesyltransferase subunit beta. Zokinvy’s patent is valid until 2024-07-26 (FDA).

 

Trade Name

 

Zokinvy
 

Common Name

 

lonafarnib
 

ChEMBL ID

 

CHEMBL298734
 

Indication

 

 

Drug Class

 

Farnesyl transferase inhibitor

Image (chem structure or protein)

Lonafarnib structure rendering